ARWR
Arrowhead Pharmaceuticals In
NASDAQ · Biotechnology
$64.52
-0.12 (-0.19%)
Performance
1D
—
1W
-11.62%
1M
-2.14%
3M
+55.47%
6M
+222.76%
1Y
+223.90%
YTD
-4.82%
Open$65.50
Previous Close$64.64
Day High$68.44
Day Low$63.46
52W High$76.76
52W Low$9.57
Volume24.09M
Avg Volume4.47M
Market Cap9.03B
P/E Ratio—
EPS$-0.06
SectorBiotechnology
Volume Analysis
5.39x average volume
Technical Indicators
SMA 50
$65.99
Below
SMA 200
$34.67
Above
RSI (14)
51.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
6 analysts
Price Target
+7.7% upside
Current
$64.52
$64.52
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 868.22M | 576.81M | 3.70B |
| Net Income | -1,708,130 | -1,021,337 | -166,552,609 |
| Profit Margin | -0.2% | -0.2% | -4.5% |
| EBITDA | 133.50M | 84.26M | -179,666,189 |
| Free Cash Flow | — | — | -111,944,748 |
| Rev Growth | +50.5% | +50.5% | -2.3% |
| Debt/Equity | 1.34 | 1.34 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |